Blue Goose Capital

Founded in 2018 and based in Cambridge, Massachusetts, Blue Goose Capital is a venture capital firm focused on investing in healthcare companies. Its primary areas of interest include biopharma, data, and device companies, with a preference for seed and series A stage investments.

Doug Zingale JD

Managing Partner

1 past transactions

AtG Therapeutics

Seed Round in 2022
AtG Therapeutics is a Barcelona-based biotechnology company spun off from IDIBELL and ICO. It focuses on developing innovative drugs and biomarkers to prevent cancer therapeutic resistance, aiming to enhance the lives of cancer patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.